Search Results 2021-2030 of 18764 for Relapse

  1. Publications - Scott C. Lester, M.D. - Mayo Clinic

    ... relapsed/refractory non-Hodgkin lymphoma: A multicenter consensus approach. Am J Hematol. 2024 Jan; 99 (1):124-134 Epub 2023 Nov 11. View PubMed; Sabharwal K ...

  2. Clinical trials - Oncology (Medical)

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...

  3. Publications - James W. Jakub, M.D. - Mayo Clinic

    ... relapse using a clinicopathologic and gene expression model. Eur J Cancer. 2020 Nov; 140:11-18 Epub 2020 Oct 05. View PubMed; Yamashita TS, Pockaj BA, Bagaria ...

  4. Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors - Mayo Clinic

    Patients must have had histologic verification of one of the malignancies listed below at original diagnosis or at relapse. Ewing sarcoma;; Rhabdomyosarcoma ...

  5. An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia - Mayo Clinic

    Study treatment should continue until there is documented disease progression, relapse from complete remission (CR), or non-manageable toxicity. A minimum ...

  6. A Study to Evaluate the Safety and Effectiveness of Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients with Crohn's Disease - Mayo Clinic

    ... relapse during maintenance treatment after initial fistula closure) while they were receiving either an immunosuppressive agent or TNF-α antagonist or ...

  7. Study finds few COVID-19 patients get rebound symptoms after Paxlovid treatment - Mayo Clinic News Network

    ROCHESTER, Minn. — Mayo Clinic researchers studied the outcomes of 483 high-risk patients treated for COVID-19 with a five-day oral regimen of nirmatrelvir ...

  8. Publications - William G. Breen, M.D. - Mayo Clinic

    ... relapsed/refractory non-Hodgkin lymphoma: A multicenter consensus approach. Am J Hematol. 2024 Jan; 99 (1):124-134 Epub 2023 Nov 11. View PubMed; Yadav U ...

  9. Clinical trials - Oncology (Medical)

    ... relapse, and subsequent therapy. Turkey Tail Mushrooms for women with ER+/HER2- Breast Cancer. Scottsdale/Phoenix, Ariz. The purpose of this study is to ...

  10. Breast radiotherapy team at Mayo Clinic adopts shortened courses to spare normal tissue

    ... relapse with standard therapy; A clinical trial investigating adjuvant poly-(ADP-ribose) polymerase inhibition with radiotherapy in inflammatory breast ...